General Information of the Compound
Compound ID
CP0076958
Compound Name
4-[(dimethylazaniumyl)amino]-4-oxobutanoate
    Show/Hide
Synonyms
Alar
B 995
B-NINE
DMASA
Kylar
SADH
daminozide
    Show/Hide
Structure
Formula
C6H12N2O3
Molecular Weight
160.173
Canonical SMILES
CN(C)NC(=O)CCC(O)=O
    Show/Hide
InChI
InChI=1S/C6H12N2O3/c1-8(2)7-5(9)3-4-6(10)11/h3-4H2,1-2H3,(H,7,9)(H,10,11)
    Show/Hide
InChIKey
NOQGZXFMHARMLW-UHFFFAOYSA-N
CAS
1861-26-3
1596-84-5
74913-15-8
Physicochemical Property
logP
-0.556
Rotatable Bonds
4
Heavy Atom Count
11
Polar Areas
69.64
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
11

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 15331
SID: 15091185
ChEMBL ID
CHEMBL2164243
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03543, Lysine-specific demethylase 5C
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000013 Sf9 Spodoptera frugiperda (Fall armyworm)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( daminozide )
Drug Name daminozide
Target(s)
Histone lysine demethylase PHF8 (PHF8)
Inhibitor
Lysine-specific demethylase 7A (KDM7A)
Inhibitor
Lysine-specific demethylase 2A (KDM2A)
Inhibitor